Myeloid Tumor Panel NGS Genetic Test
At DNA Labs UAE, we offer the Myeloid Tumor Panel NGS Genetic Test at a cost of AED 4400.0. This test is designed to identify mutations in genes associated with myeloid tumors, including acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.
Test Details
The Myeloid Tumor Panel NGS Genetic DNA Test is a type of genetic test that analyzes a patient’s DNA for mutations in a panel of genes commonly associated with myeloid tumors. These genes include FLT3, NPM1, IDH1, IDH2, TP53, and others.
By identifying specific mutations in these genes, the test can provide valuable information about a patient’s prognosis and help guide treatment decisions. Certain mutations may indicate a higher risk of disease progression or a greater likelihood of responding to specific therapies.
Test Components and Price
The cost of the Myeloid Tumor Panel NGS Genetic DNA Test is AED 4400.0. The test requires a blood sample or extracted DNA. Alternatively, one drop of blood can be collected on an FTA card for testing.
Report Delivery
The report for the Myeloid Tumor Panel NGS Genetic DNA Test is typically delivered within 3 to 4 weeks.
Test Method
The Myeloid Tumor Panel NGS Genetic DNA Test utilizes next-generation sequencing (NGS) technology to analyze the patient’s DNA for mutations.
Referring Doctor and Test Department
This test is typically referred by an Oncologist and is conducted in the Genetics department.
Pre-Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the Myeloid Tumor Panel NGS Genetic DNA Test. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with ASXL1, ATM, CBL, CDKN2A, CEBPA, CREBBP, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, NF1, NOTCH1, NPM1, NRAS, PDGFRB, PHF6, PTPN11, RAD21, RUNX1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, and WT1 genes.
Conclusion
The Myeloid Tumor Panel NGS Genetic DNA Test is a valuable tool for diagnosing and managing myeloid tumors. By identifying specific mutations in genes associated with these tumors, this test can provide personalized treatment options and improve patient outcomes.
Test Name | Myeloid tumor panel NGS Genetic DNA Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for Myeloid tumor panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ASXL1, ATM, CBL, CDKN2A, CEBPA, CREBBP, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, NF1, NOTCH1, NPM1, NRAS, PDGFRB, PHF6, PTPN11, RAD21, RUNX1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, WT1 |
Test Details | The Myeloid Tumor Panel NGS Genetic DNA Test is a type of genetic test that is used to identify mutations in genes associated with myeloid tumors. Myeloid tumors are a type of cancer that affects the bone marrow and blood cells, and can include acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. The test uses next-generation sequencing (NGS) technology to analyze a patient’s DNA for mutations in a panel of genes that are commonly associated with myeloid tumors. These genes include FLT3, NPM1, IDH1, IDH2, TP53, and others. By identifying specific mutations in these genes, the test can help doctors determine a patient’s prognosis and guide treatment decisions. For example, certain mutations may indicate a higher risk of disease progression or a greater likelihood of responding to specific therapies. Overall, the Myeloid Tumor Panel NGS Genetic DNA Test is a valuable tool for diagnosing and managing myeloid tumors, and can help improve patient outcomes by providing personalized treatment options. |